| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion binding | 3.42e-08 | 14 | 50 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.99e-07 | 26 | 50 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 4.99e-07 | 26 | 50 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | transporter activity | SLC38A1 SIDT2 ABCA3 ANO6 SCN1A SCN2A SCN3A SCN8A SIDT1 APOB ITGAV SLC38A6 RYR1 ABCB1 | 2.12e-06 | 1289 | 50 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC38A1 SIDT2 ABCA3 ANO6 SCN1A SCN2A SCN3A SCN8A SIDT1 ITGAV SLC38A6 RYR1 ABCB1 | 4.58e-06 | 1180 | 50 | 13 | GO:0022857 |
| GeneOntologyMolecularFunction | sodium channel activity | 8.62e-06 | 52 | 50 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | RNA transmembrane transporter activity | 1.84e-05 | 3 | 50 | 2 | GO:0051033 | |
| GeneOntologyMolecularFunction | nucleic acid transmembrane transporter activity | 1.84e-05 | 3 | 50 | 2 | GO:0051032 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.20e-05 | 343 | 50 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR1N1 FZD6 GPR65 OR5AU1 MLNR CYSLTR1 OR1L6 OR2T4 PTGER2 OR1L4 | 5.63e-05 | 884 | 50 | 10 | GO:0004930 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 6.74e-05 | 171 | 50 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 9.05e-05 | 182 | 50 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 9.53e-05 | 184 | 50 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.38e-04 | 459 | 50 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.49e-04 | 465 | 50 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | L-glutamine transmembrane transporter activity | 2.19e-04 | 9 | 50 | 2 | GO:0015186 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.24e-04 | 664 | 50 | 8 | GO:0008324 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.83e-04 | 51 | 50 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | channel activity | 3.13e-04 | 525 | 50 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.17e-04 | 526 | 50 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.43e-04 | 758 | 50 | 8 | GO:0015318 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 5.49e-04 | 14 | 50 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 6.32e-04 | 15 | 50 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 7.21e-04 | 16 | 50 | 2 | GO:0004953 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 7.30e-04 | 793 | 50 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 8.16e-04 | 17 | 50 | 2 | GO:0099508 | |
| GeneOntologyMolecularFunction | flippase activity | 8.16e-04 | 17 | 50 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 8.45e-04 | 74 | 50 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 9.00e-04 | 627 | 50 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 1.13e-03 | 20 | 50 | 2 | GO:0008525 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.45e-03 | 334 | 50 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.46e-03 | 196 | 50 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR1N1 FZD6 GPR65 OR5AU1 MLNR CYSLTR1 OR1L6 OR2T4 PTGER2 OR1L4 | 1.67e-03 | 1353 | 50 | 10 | GO:0004888 |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.92e-03 | 26 | 50 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.23e-03 | 28 | 50 | 2 | GO:0140326 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 3.28e-03 | 34 | 50 | 2 | GO:0022884 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.28e-03 | 34 | 50 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 4.29e-03 | 39 | 50 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 4.37e-03 | 431 | 50 | 5 | GO:0004984 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 4.73e-03 | 41 | 50 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.93e-03 | 46 | 50 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.70e-03 | 49 | 50 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | lipid transfer activity | 8.98e-03 | 57 | 50 | 2 | GO:0120013 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 9.60e-03 | 59 | 50 | 2 | GO:0015932 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.70e-06 | 36 | 50 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.07e-05 | 208 | 50 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.54e-05 | 62 | 50 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.64e-05 | 63 | 50 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 5.17e-05 | 275 | 50 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 5.86e-05 | 87 | 50 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 7.61e-05 | 93 | 50 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.56e-04 | 112 | 50 | 4 | GO:0019226 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.77e-04 | 217 | 50 | 5 | GO:0006941 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.11e-04 | 121 | 50 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 2.54e-04 | 127 | 50 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | glutamine transport | 2.56e-04 | 10 | 50 | 2 | GO:0006868 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 2.91e-04 | 1115 | 50 | 10 | GO:0034220 | |
| GeneOntologyBiologicalProcess | circulatory system process | 3.51e-04 | 733 | 50 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC38A1 RELN ANO6 CYSLTR1 SCN1A SCN2A SCN3A SCN8A ITGAV RYR1 ABCB1 | 3.68e-04 | 1374 | 50 | 11 | GO:0006811 |
| GeneOntologyBiologicalProcess | lipid translocation | 4.16e-04 | 60 | 50 | 3 | GO:0034204 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane transport | 5.10e-04 | 273 | 50 | 5 | GO:0034764 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 5.14e-04 | 153 | 50 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | female meiosis I | 5.14e-04 | 14 | 50 | 2 | GO:0007144 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 5.27e-04 | 65 | 50 | 3 | GO:0097035 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 6.74e-08 | 17 | 50 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 6.58e-07 | 29 | 50 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | node of Ranvier | 1.43e-05 | 20 | 50 | 3 | GO:0033268 | |
| GeneOntologyCellularComponent | axon initial segment | 4.50e-05 | 29 | 50 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | external side of apical plasma membrane | 8.36e-05 | 6 | 50 | 2 | GO:0098591 | |
| GeneOntologyCellularComponent | cation channel complex | 2.41e-04 | 235 | 50 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.73e-04 | 378 | 50 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | T-tubule | 8.96e-04 | 79 | 50 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | main axon | 1.27e-03 | 89 | 50 | 3 | GO:0044304 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.49e-03 | 523 | 50 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 1.92e-03 | 550 | 50 | 6 | GO:1990351 | |
| HumanPheno | Focal automatism seizure | 1.03e-07 | 12 | 21 | 4 | HP:0032898 | |
| HumanPheno | Simple febrile seizure | 3.52e-06 | 27 | 21 | 4 | HP:0011171 | |
| HumanPheno | Clonic seizure | 1.50e-05 | 81 | 21 | 5 | HP:0020221 | |
| HumanPheno | Focal non-motor seizure | 1.77e-05 | 40 | 21 | 4 | HP:0032679 | |
| HumanPheno | Impulsivity | 2.14e-05 | 149 | 21 | 6 | HP:0100710 | |
| HumanPheno | Focal clonic seizure | 2.16e-05 | 42 | 21 | 4 | HP:0002266 | |
| HumanPheno | Complex febrile seizure | 3.27e-05 | 16 | 21 | 3 | HP:0011172 | |
| HumanPheno | Bilateral tonic-clonic seizure with focal onset | 5.08e-05 | 52 | 21 | 4 | HP:0007334 | |
| HumanPheno | Focal sensory seizure | 8.84e-05 | 22 | 21 | 3 | HP:0011157 | |
| HumanPheno | Epileptic encephalopathy | 9.65e-05 | 119 | 21 | 5 | HP:0200134 | |
| HumanPheno | Focal impaired awareness seizure | 1.27e-04 | 126 | 21 | 5 | HP:0002384 | |
| HumanPheno | Focal hemiclonic seizure | 1.31e-04 | 25 | 21 | 3 | HP:0006813 | |
| HumanPheno | Epileptic aura | 1.31e-04 | 25 | 21 | 3 | HP:0033348 | |
| HumanPheno | Neonatal electro-clinical non-motor seizure | 1.61e-04 | 5 | 21 | 2 | HP:0032812 | |
| HumanPheno | Neonatal seizure with electrographic correlate | 1.61e-04 | 5 | 21 | 2 | HP:0032808 | |
| HumanPheno | Neonatal electro-clinical seizure | 1.61e-04 | 5 | 21 | 2 | HP:0032809 | |
| HumanPheno | Neonatal electro-clinical seizure with behavior arrest | 1.61e-04 | 5 | 21 | 2 | HP:0032823 | |
| HumanPheno | Focal head nodding automatism seizure | 1.61e-04 | 5 | 21 | 2 | HP:0032906 | |
| HumanPheno | Rigidity | 1.64e-04 | 214 | 21 | 6 | HP:0002063 | |
| HumanPheno | Focal aware seizure | 1.85e-04 | 28 | 21 | 3 | HP:0002349 | |
| HumanPheno | Mortality/Aging | 1.99e-04 | 563 | 21 | 9 | HP:0040006 | |
| HumanPheno | Age of death | 1.99e-04 | 563 | 21 | 9 | HP:0011420 | |
| HumanPheno | Normal interictal EEG | 2.40e-04 | 6 | 21 | 2 | HP:0002372 | |
| HumanPheno | Cavernous hemangioma | 2.52e-04 | 31 | 21 | 3 | HP:0001048 | |
| HumanPheno | Decreased fetal movement | 2.67e-04 | 234 | 21 | 6 | HP:0001558 | |
| HumanPheno | Generalized clonic seizure | 3.33e-04 | 34 | 21 | 3 | HP:0011169 | |
| HumanPheno | Eyelid myoclonia seizure | 3.36e-04 | 7 | 21 | 2 | HP:0032678 | |
| HumanPheno | Prenatal movement abnormality | 3.51e-04 | 246 | 21 | 6 | HP:0001557 | |
| HumanPheno | EEG with abnormally slow frequencies | 3.98e-04 | 88 | 21 | 4 | HP:0011203 | |
| HumanPheno | Photosensitive myoclonic seizure | 4.47e-04 | 8 | 21 | 2 | HP:0001327 | |
| HumanPheno | Cyanotic episode | 4.47e-04 | 8 | 21 | 2 | HP:0200048 | |
| HumanPheno | Macrocephaly at birth | 5.73e-04 | 9 | 21 | 2 | HP:0004488 | |
| HumanPheno | Aggressive behavior | 6.47e-04 | 516 | 21 | 8 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 6.47e-04 | 516 | 21 | 8 | HP:0006919 | |
| HumanPheno | Sudden unexpected death in epilepsy | 7.14e-04 | 10 | 21 | 2 | HP:0033258 | |
| HumanPheno | Psychic epileptic aura | 7.14e-04 | 10 | 21 | 2 | HP:0033346 | |
| HumanPheno | Experiential epileptic aura | 7.14e-04 | 10 | 21 | 2 | HP:0012002 | |
| HumanPheno | Hypsarrhythmia | 7.58e-04 | 185 | 21 | 5 | HP:0002521 | |
| HumanPheno | Neonatal seizure | 8.71e-04 | 11 | 21 | 2 | HP:0032807 | |
| HumanPheno | Focal autonomic seizure | 8.71e-04 | 11 | 21 | 2 | HP:0011154 | |
| HumanPheno | Limited neck range of motion | 8.71e-04 | 11 | 21 | 2 | HP:0000466 | |
| HumanPheno | Epilepsia partialis continua | 1.04e-03 | 12 | 21 | 2 | HP:0012847 | |
| HumanPheno | Abnormal fetal physiology | 1.16e-03 | 308 | 21 | 6 | HP:0034059 | |
| HumanPheno | Cyanosis | 1.17e-03 | 117 | 21 | 4 | HP:0000961 | |
| HumanPheno | EEG with multifocal slow activity | 1.17e-03 | 52 | 21 | 3 | HP:0010844 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.21e-03 | 118 | 21 | 4 | HP:0011185 | |
| HumanPheno | Generalized cerebral atrophy/hypoplasia | 1.23e-03 | 13 | 21 | 2 | HP:0007058 | |
| HumanPheno | Status epilepticus | 1.26e-03 | 207 | 21 | 5 | HP:0002133 | |
| MousePheno | abnormal respiratory function | 7.67e-06 | 399 | 37 | 8 | MP:0002327 | |
| MousePheno | abnormal breathing pattern | 1.24e-05 | 303 | 37 | 7 | MP:0001951 | |
| MousePheno | abnormal respiratory system physiology | 7.98e-05 | 897 | 37 | 10 | MP:0002133 | |
| MousePheno | abnormal extraocular muscle morphology | 1.02e-04 | 6 | 37 | 2 | MP:0005247 | |
| MousePheno | abnormal respiration | 1.37e-04 | 598 | 37 | 8 | MP:0001943 | |
| MousePheno | respiratory distress | 1.88e-04 | 204 | 37 | 5 | MP:0001954 | |
| Domain | Na_trans_cytopl | 6.25e-10 | 6 | 49 | 4 | PF11933 | |
| Domain | Na_trans_cytopl | 6.25e-10 | 6 | 49 | 4 | IPR024583 | |
| Domain | Na_channel_asu | 8.68e-09 | 10 | 49 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 8.68e-09 | 10 | 49 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 8.68e-09 | 10 | 49 | 4 | PF06512 | |
| Domain | SID1_TM_fam | 6.74e-06 | 2 | 49 | 2 | IPR025958 | |
| Domain | SID-1_RNA_chan | 6.74e-06 | 2 | 49 | 2 | PF13965 | |
| Domain | Ion_trans_dom | 1.19e-05 | 114 | 49 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.19e-05 | 114 | 49 | 5 | PF00520 | |
| Domain | Channel_four-helix_dom | 1.49e-05 | 57 | 49 | 4 | IPR027359 | |
| Domain | - | 1.49e-05 | 57 | 49 | 4 | 1.20.120.350 | |
| Domain | GPCR_Rhodpsn_7TM | 5.29e-05 | 670 | 49 | 9 | IPR017452 | |
| Domain | 7tm_1 | 5.74e-05 | 677 | 49 | 9 | PF00001 | |
| Domain | IQ | 6.00e-05 | 81 | 49 | 4 | SM00015 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 6.28e-05 | 685 | 49 | 9 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 6.72e-05 | 691 | 49 | 9 | PS50262 | |
| Domain | GPCR_Rhodpsn | 6.79e-05 | 692 | 49 | 9 | IPR000276 | |
| Domain | IQ_motif_EF-hand-BS | 9.05e-05 | 90 | 49 | 4 | IPR000048 | |
| Domain | EF-hand-dom_pair | 1.00e-04 | 287 | 49 | 6 | IPR011992 | |
| Domain | IQ | 1.03e-04 | 93 | 49 | 4 | PS50096 | |
| Domain | IQ | 8.56e-04 | 71 | 49 | 3 | PF00612 | |
| Domain | Aa_trans | 8.94e-04 | 17 | 49 | 2 | PF01490 | |
| Domain | AA_transpt_TM | 8.94e-04 | 17 | 49 | 2 | IPR013057 | |
| Domain | EF-hand_8 | 3.59e-03 | 34 | 49 | 2 | PF13833 | |
| Domain | Olfact_rcpt | 3.59e-03 | 393 | 49 | 5 | IPR000725 | |
| Domain | ABC_transporter_CS | 5.43e-03 | 42 | 49 | 2 | IPR017871 | |
| Domain | ABC_TRANSPORTER_2 | 7.04e-03 | 48 | 49 | 2 | PS50893 | |
| Domain | ABC_tran | 7.04e-03 | 48 | 49 | 2 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 7.33e-03 | 49 | 49 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 7.62e-03 | 50 | 49 | 2 | IPR003439 | |
| Pathway | WP_DRAVET_SYNDROME | 9.76e-07 | 28 | 39 | 4 | M45519 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.49e-06 | 31 | 39 | 4 | M877 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 1.70e-06 | 32 | 39 | 4 | M27455 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.95e-05 | 121 | 39 | 5 | M872 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.76e-05 | 130 | 39 | 5 | M27454 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.28e-04 | 203 | 39 | 5 | M5485 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.92e-04 | 636 | 39 | 8 | M41834 | |
| Pathway | WP_RETT_SYNDROME | 3.11e-04 | 48 | 39 | 3 | M39759 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 6.65e-04 | 14 | 39 | 2 | MM15012 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 7.65e-04 | 15 | 39 | 2 | M10620 | |
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 17537961 | ||
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 35031483 | ||
| Pubmed | 3.78e-12 | 4 | 50 | 4 | 29578003 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 5.66e-11 | 6 | 50 | 4 | 23652591 | |
| Pubmed | 4.74e-10 | 9 | 50 | 4 | 16382098 | ||
| Pubmed | 4.74e-10 | 9 | 50 | 4 | 15746173 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 1.85e-09 | 12 | 50 | 4 | 30175250 | |
| Pubmed | 2.68e-09 | 13 | 50 | 4 | 15123669 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 23859570 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 12610651 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 18784617 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 17544618 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 32845893 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 28518218 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 17928448 | ||
| Pubmed | 2.80e-09 | 3 | 50 | 3 | 14973256 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 35801810 | ||
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 21156207 | ||
| Pubmed | Use of recombinant inbred strains for studying genetic determinants of responses to alcohol. | 1.12e-08 | 4 | 50 | 3 | 8974318 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 1679748 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 8812438 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 24337656 | ||
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 17724025 | ||
| Pubmed | Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. | 9.75e-08 | 7 | 50 | 3 | 25818041 | |
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 20602612 | ||
| Pubmed | 6.09e-07 | 12 | 50 | 3 | 8169823 | ||
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 1.26e-06 | 15 | 50 | 3 | 9726281 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 20346423 | ||
| Pubmed | Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy. | 2.03e-06 | 2 | 50 | 2 | 37901435 | |
| Pubmed | An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior. | 2.03e-06 | 2 | 50 | 2 | 26410685 | |
| Pubmed | Neuronal death and perinatal lethality in voltage-gated sodium channel alpha(II)-deficient mice. | 2.03e-06 | 2 | 50 | 2 | 10827969 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19694741 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 35348308 | ||
| Pubmed | Genomic structures of SCN2A and SCN3A - candidate genes for deafness at the DFNA16 locus. | 2.03e-06 | 2 | 50 | 2 | 11245985 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15760941 | ||
| Pubmed | Differential expression of two sodium channel subtypes in human brain. | 2.03e-06 | 2 | 50 | 2 | 1317301 | |
| Pubmed | Duplication of the sodium channel gene cluster on 2q24 in children with early onset epilepsy. | 2.03e-06 | 2 | 50 | 2 | 23016767 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 27153334 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 24447140 | ||
| Pubmed | Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A. | 2.03e-06 | 2 | 50 | 2 | 24990319 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 31439038 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 23786015 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 31943325 | ||
| Pubmed | A novel family of mammalian transmembrane proteins involved in cholesterol transport. | 2.03e-06 | 2 | 50 | 2 | 28785058 | |
| Pubmed | Severe epilepsy, retardation, and dysmorphic features with a 2q deletion including SCN1A and SCN2A. | 2.03e-06 | 2 | 50 | 2 | 15249644 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 27690330 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18601978 | ||
| Pubmed | Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome. | 2.03e-06 | 2 | 50 | 2 | 23965409 | |
| Pubmed | FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. | 2.03e-06 | 2 | 50 | 2 | 19465131 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 30693367 | ||
| Pubmed | Block of a subset of sodium channels exacerbates experimental autoimmune encephalomyelitis. | 2.03e-06 | 2 | 50 | 2 | 23735284 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 29649454 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 33096315 | ||
| Pubmed | Sodium channel expression within chronic multiple sclerosis plaques. | 2.03e-06 | 2 | 50 | 2 | 17805013 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26311622 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 33411788 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 26067272 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 21377452 | ||
| Pubmed | Persistent Nav1.1 and Nav1.6 currents drive spinal locomotor functions through nonlinear dynamics. | 2.03e-06 | 2 | 50 | 2 | 37665666 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17881658 | ||
| Pubmed | Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. | 3.42e-06 | 71 | 50 | 4 | 8751373 | |
| Pubmed | 3.65e-06 | 21 | 50 | 3 | 23137377 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19284629 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 32185219 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 32005694 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 33895391 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 16033895 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 27816501 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 18276918 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 18696186 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 38514708 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 26182346 | ||
| Pubmed | De novo SCN1A, SCN8A, and CLCN2 mutations in childhood absence epilepsy. | 6.07e-06 | 3 | 50 | 2 | 31054517 | |
| Pubmed | Localization of the reeler gene relative to flanking loci on mouse chromosome 5. | 6.07e-06 | 3 | 50 | 2 | 1686837 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 28784306 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 35381649 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 20376628 | ||
| Pubmed | Role of sodium channel subtype in action potential generation by neocortical pyramidal neurons. | 6.07e-06 | 3 | 50 | 2 | 29991598 | |
| Pubmed | Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. | 6.07e-06 | 3 | 50 | 2 | 24704313 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 19270815 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 16052353 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 25155934 | ||
| Pubmed | The sorting receptor Rer1 controls Purkinje cell function via voltage gated sodium channels. | 6.07e-06 | 3 | 50 | 2 | 28117367 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 34411648 | ||
| Pubmed | [Genetic analysis for prevention of steroid-induced osteonecrosis of the femoral head]. | 6.07e-06 | 3 | 50 | 2 | 17548929 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 7734734 | ||
| Pubmed | Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms. | 1.21e-05 | 4 | 50 | 2 | 26637798 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 19273625 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 7777557 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 24145140 | ||
| Pubmed | Models for discovery of targeted therapy in genetic epileptic encephalopathies. | 1.21e-05 | 4 | 50 | 2 | 28742937 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 26279426 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 1627461 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 23744557 | ||
| Pubmed | Estimation of genetic distances between "reeler" and nearby loci on mouse chromosome 5. | 1.21e-05 | 4 | 50 | 2 | 1783386 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 30896644 | ||
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 32243098 | ||
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 2.02e-05 | 5 | 50 | 2 | 22875929 | |
| Pubmed | Structure, genetic mapping, and expression of the mouse Hgf/scatter factor gene. | 2.02e-05 | 5 | 50 | 2 | 8081873 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 24077057 | ||
| Interaction | SCN4B interactions | 6.18e-07 | 8 | 46 | 3 | int:SCN4B | |
| Interaction | TMPRSS12 interactions | 1.91e-05 | 23 | 46 | 3 | int:TMPRSS12 | |
| Interaction | ADGRG5 interactions | 5.98e-05 | 93 | 46 | 4 | int:ADGRG5 | |
| Interaction | TMPRSS4 interactions | 7.56e-05 | 314 | 46 | 6 | int:TMPRSS4 | |
| Cytoband | 9q33.2 | 1.08e-05 | 39 | 50 | 3 | 9q33.2 | |
| Cytoband | 2q24.3 | 1.38e-04 | 16 | 50 | 2 | 2q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 3.68e-04 | 127 | 50 | 3 | chr2q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q33 | 4.70e-04 | 138 | 50 | 3 | chr9q33 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.07e-09 | 9 | 38 | 4 | 1203 | |
| GeneFamily | Olfactory receptors, family 1 | 8.02e-05 | 40 | 38 | 3 | 147 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL | 7.02e-06 | 402 | 47 | 7 | M45754 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN | 2.91e-05 | 200 | 47 | 5 | M8027 | |
| Coexpression | FEKIR_HEPARG_SPHERE_VS_HEPARG_UP | 3.52e-05 | 103 | 47 | 4 | M48358 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 163 | 50 | 5 | 2f32a9ab0230fdca98ffa7fd59397301d50e4f30 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 163 | 50 | 5 | 6c2967dee563295febe2adabf503d095cb911ccf | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-06 | 165 | 50 | 5 | 347b59aa625a8a960828b8620824d8ac48990e07 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-06 | 165 | 50 | 5 | 507c89ece0a336b8e9c65b79889a714e17ddca27 | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-06 | 165 | 50 | 5 | 39a25be081a5d59c7cf107a997d352793d5025fb | |
| ToppCell | PND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-06 | 165 | 50 | 5 | 1890f9c33b0c5b381d57f97042da2610a093a6de | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-06 | 169 | 50 | 5 | f077e39e41fffe7672541f5b72b80faaf56c597c | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-06 | 170 | 50 | 5 | 35e3945d8a540a3e2cec1b559316265aaad023d1 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-06 | 170 | 50 | 5 | 0ea625abaa25bab93b70b7000e8f90d5c0f9a0fb | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-06 | 170 | 50 | 5 | 0b5ddc7d452db0a389927a367914f7d257703f7e | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 1.63e-06 | 177 | 50 | 5 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.98e-06 | 184 | 50 | 5 | 33db879e629821fb75684e60f8f0749cf9623bdd | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-05 | 142 | 50 | 4 | be63c48794a227ea55978524c0f5935342fc455e | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 152 | 50 | 4 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 155 | 50 | 4 | d0c1608f8f6b6f4174e51d610501c707cba5e015 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-05 | 161 | 50 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-05 | 161 | 50 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-05 | 161 | 50 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-05 | 162 | 50 | 4 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-05 | 164 | 50 | 4 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-05 | 164 | 50 | 4 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-05 | 164 | 50 | 4 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.44e-05 | 164 | 50 | 4 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.52e-05 | 165 | 50 | 4 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.61e-05 | 166 | 50 | 4 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 166 | 50 | 4 | aa2df07eff323ded751ced8938af08223d7f2029 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 166 | 50 | 4 | 8e5a262dc4f04c5fc75b9a7a907832a0d7877df0 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.61e-05 | 166 | 50 | 4 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 166 | 50 | 4 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-05 | 166 | 50 | 4 | 695298a94d62b8adab083900003ec636fbaae5d9 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-05 | 167 | 50 | 4 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-05 | 167 | 50 | 4 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-05 | 167 | 50 | 4 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 167 | 50 | 4 | c2952d8ba763374c5678b92825c8956fc3e3ecd2 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.69e-05 | 167 | 50 | 4 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | droplet-Bladder-nan-24m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 168 | 50 | 4 | c6e0daa790dd5db20dd1ab8c1e7142484976d743 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 169 | 50 | 4 | b46e446067c6425bd5b8ef7719aeecff5e861249 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 169 | 50 | 4 | 7a7416fcbffcf57d19b477d9da091e04e3499524 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 169 | 50 | 4 | 5508b03fbf483fce7701d6c82c297ffda3b1ba05 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 169 | 50 | 4 | 0e1a99cd77edcf32bcb513abd247b2b27409ac63 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 169 | 50 | 4 | 9bbad31ef03078f5aa456f2e1b17b49c91545ff0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.96e-05 | 170 | 50 | 4 | f664c7559e383b37845c123e41a3be316d869ba0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.96e-05 | 170 | 50 | 4 | 0272eb1487c2545d4aa06f5d1cd77f823e1441e9 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.05e-05 | 171 | 50 | 4 | 87cb65648c663e246f94cea1a5ed12e8e29ec629 | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 171 | 50 | 4 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.05e-05 | 171 | 50 | 4 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | droplet-Trachea-nan-3m-Myeloid-macrophage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 172 | 50 | 4 | f6c00a6a7e81aaf96c55eb3a3c88e3719f102ea0 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid-myeloid_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 172 | 50 | 4 | 6b01448443cf8392ed8248ff452b80c31240b85d | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-tracheal_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.14e-05 | 172 | 50 | 4 | f3bbe3f069ad070778430d1a6cd9db0a76deb8de | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 172 | 50 | 4 | 0c0ae2da3cba6022403434567800f16e61a34a2b | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-05 | 172 | 50 | 4 | d80c207f3489be2da2f40f47a7835cb73c949c3e | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 173 | 50 | 4 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.43e-05 | 175 | 50 | 4 | 8fb8c4b9e2d9b7d737f59cd9bd3dc2bca5a8dfc4 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-ILC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.63e-05 | 177 | 50 | 4 | 9828504591599619649d41a78daf7c052729c669 | |
| ToppCell | Control-Lymphoid-ILC_B|Control / Disease state, Lineage and Cell class | 4.63e-05 | 177 | 50 | 4 | 3d0f4b4054185ba77071efbe53df34fee84b9b24 | |
| ToppCell | LPS_only-Myeloid-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-05 | 179 | 50 | 4 | d0a03e498afcfeb657037889685ecd77bed07e6c | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.84e-05 | 179 | 50 | 4 | ab3d08b51cd7a37582305615ee221c7a2af83b40 | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.84e-05 | 179 | 50 | 4 | 2285e3a9018a60d7f6e974fee46b6f61d39aa76f | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.84e-05 | 179 | 50 | 4 | 0b0f27d7c5cc5ae7618d887dcfa7219df8ff1935 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.84e-05 | 179 | 50 | 4 | 35fe9961e228ce255e3317fc244efa35b5adbf8b | |
| ToppCell | 3'-Adult-Appendix-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.84e-05 | 179 | 50 | 4 | 63bc819df62b1f8f37bf1f17bdd4fcc161886923 | |
| ToppCell | LPS_only-Myeloid-Neutrophils-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.84e-05 | 179 | 50 | 4 | d034651a5a355a58f5e15db627869f4feebdfe35 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 180 | 50 | 4 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 180 | 50 | 4 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-05 | 180 | 50 | 4 | c0c07937839652e01df10cc1e70aa005800ea6f6 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.94e-05 | 180 | 50 | 4 | 079c199425dd3c220f03c6dca1823946f07580a1 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.05e-05 | 181 | 50 | 4 | 57f20341c3e9f9f6ed5b6c181605ad35bae91414 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.05e-05 | 181 | 50 | 4 | 51e4d6bfdbf414d8e30aee2e6f7492f4f7f54373 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 182 | 50 | 4 | d22ab50b135482915687c70e6dad29bfe2bb2c68 | |
| ToppCell | LPS_only-Myeloid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 182 | 50 | 4 | 666ac86ee5f6fa9241ae8d80340743707e54b278 | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.16e-05 | 182 | 50 | 4 | 8ccffcbae28c374fd4161fb0d4cf2c49fae557f6 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.27e-05 | 183 | 50 | 4 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.50e-05 | 185 | 50 | 4 | 8fc357ee041bfd588986730a52ea2021b5f88941 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.50e-05 | 185 | 50 | 4 | f30fb9d75cdb757b206312992aaf7485bc900f96 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.50e-05 | 185 | 50 | 4 | 3be9e05b929ac4d956b1d53284072f668a6c1959 | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-05 | 185 | 50 | 4 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-lymphatic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.50e-05 | 185 | 50 | 4 | c3dd64a726cb8a1fe048683c266b7532a714a52e | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 5.61e-05 | 186 | 50 | 4 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.61e-05 | 186 | 50 | 4 | bca5215d406f1785bf3a420201d5686071fcaca5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-05 | 186 | 50 | 4 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_natural_killer_[NK]_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.73e-05 | 187 | 50 | 4 | b5c8322ee728303425be677aa0c36fa552fd0f59 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.73e-05 | 187 | 50 | 4 | 9d298f43ae81d72091b31aaa6df41046d4aa31c5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 187 | 50 | 4 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 187 | 50 | 4 | 2d17408b3b5f09d135084fd7ccce98e6b5ca632b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 187 | 50 | 4 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.85e-05 | 188 | 50 | 4 | 624426815b789f0f35c327b8c3c0c05ba3aa7d98 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.85e-05 | 188 | 50 | 4 | 1082861eb9e00409caa06d8b2a7b8e7f5fac94c9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.97e-05 | 189 | 50 | 4 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 5.97e-05 | 189 | 50 | 4 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.97e-05 | 189 | 50 | 4 | c604da558c9f4055fb36218452463539f2a73223 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.97e-05 | 189 | 50 | 4 | a438c64a893d43f781ede42e1c7b615b74dc76ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-05 | 189 | 50 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.10e-05 | 190 | 50 | 4 | bee6a438e217b2abd57aef2a80a9fe14a298d223 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.10e-05 | 190 | 50 | 4 | e5625feb21915d4545cfad2659745ef180efcb1f | |
| ToppCell | PCW_10-12-Immune_Lymphocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.10e-05 | 190 | 50 | 4 | 9b56763d62e1ed50006a5b90b160c5a82aab515b | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.22e-05 | 191 | 50 | 4 | 5696e2e2db7b898a1c7ab3582ae74cb712dd5bdf | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 6.22e-05 | 191 | 50 | 4 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.35e-05 | 192 | 50 | 4 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.35e-05 | 192 | 50 | 4 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | ASK454|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.35e-05 | 192 | 50 | 4 | 6b047b445a0df0ecdd6d7baf388a0d966a93b3a2 | |
| Computational | Neighborhood of RAB7L1 | 8.20e-05 | 33 | 28 | 3 | GNF2_RAB7L1 | |
| Computational | B lymphoma expression clusters. | 1.89e-04 | 112 | 28 | 4 | MODULE_456 | |
| Computational | Neighborhood of PTPN4 | 2.86e-04 | 50 | 28 | 3 | GNF2_PTPN4 | |
| Computational | Genes in the cancer module 237. | 4.44e-04 | 58 | 28 | 3 | MODULE_237 | |
| Drug | fenvalerate | 6.98e-08 | 97 | 50 | 6 | ctd:C017690 | |
| Drug | APETx1, Anthopleura elegantissima | 1.98e-07 | 6 | 50 | 3 | ctd:C475726 | |
| Drug | 2,3,5,6-tetrafluoro-4-methylbenzyl (Z)-(1RS)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate | 5.54e-07 | 8 | 50 | 3 | ctd:C489827 | |
| Drug | Zonisamide | 6.63e-06 | 17 | 50 | 3 | DB00909 | |
| Drug | AC1L1H8O | 9.16e-06 | 60 | 50 | 4 | CID000005106 | |
| Drug | phenyltetrazole | 1.42e-05 | 3 | 50 | 2 | CID000087425 | |
| Drug | globotriaosylceramide | 1.42e-05 | 3 | 50 | 2 | ctd:C018549 | |
| Drug | 24-norcholan-2,3,24-tryl-2,3,23-sulfuric acid | 2.83e-05 | 4 | 50 | 2 | ctd:C562251 | |
| Drug | lithocholate-3-O-glucuronide | 2.83e-05 | 4 | 50 | 2 | CID000126511 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 2.83e-05 | 4 | 50 | 2 | ctd:C501880 | |
| Drug | Sodium | 3.49e-05 | 84 | 50 | 4 | ctd:D012964 | |
| Drug | AC1NSZ76 | 4.71e-05 | 5 | 50 | 2 | CID005320215 | |
| Drug | acetic anhydride | 4.71e-05 | 5 | 50 | 2 | ctd:C031800 | |
| Drug | verlukast | 4.73e-05 | 32 | 50 | 3 | ctd:C059141 | |
| Drug | coprostanol | 4.73e-05 | 32 | 50 | 3 | CID000003240 | |
| Drug | NSC643733 | 5.20e-05 | 93 | 50 | 4 | CID000054688 | |
| Drug | Glucosamine | 5.93e-05 | 311 | 50 | 6 | ctd:D005944 | |
| Drug | isotetrandrine | 6.13e-05 | 97 | 50 | 4 | CID000005422 | |
| Drug | fenpropathrin | 7.05e-05 | 6 | 50 | 2 | ctd:C044267 | |
| Drug | alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol | 7.05e-05 | 6 | 50 | 2 | ctd:C049740 | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; MCF7; HT_HG-U133A | 7.65e-05 | 200 | 50 | 5 | 5679_UP | |
| Drug | Tetrodotoxin | 9.30e-05 | 40 | 50 | 3 | ctd:D013779 | |
| Drug | Oacsa | 9.86e-05 | 7 | 50 | 2 | CID006438472 | |
| Drug | aliskiren | 9.86e-05 | 7 | 50 | 2 | ctd:C446481 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.18e-09 | 10 | 47 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.18e-09 | 10 | 47 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.77e-09 | 12 | 47 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | anxiety disorder (implicated_via_orthology) | 5.71e-06 | 22 | 47 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 6.15e-06 | 163 | 47 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Benign familial infantile epilepsy | 7.44e-06 | 3 | 47 | 2 | cv:C5575231 | |
| Disease | Epilepsy, Cryptogenic | 9.02e-06 | 82 | 47 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 9.02e-06 | 82 | 47 | 4 | C0751111 | |
| Disease | Aura | 9.02e-06 | 82 | 47 | 4 | C0236018 | |
| Disease | Epilepsy | 2.78e-05 | 109 | 47 | 4 | C0014544 | |
| Disease | Familial benign neonatal epilepsy | 3.71e-05 | 6 | 47 | 2 | C0220669 | |
| Disease | Seizure, Febrile, Simple | 5.19e-05 | 7 | 47 | 2 | C0149886 | |
| Disease | Seizure, Febrile, Complex | 5.19e-05 | 7 | 47 | 2 | C0751057 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 6.91e-05 | 8 | 47 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | obstructive sleep apnea (biomarker_via_orthology) | 6.91e-05 | 8 | 47 | 2 | DOID:0050848 (biomarker_via_orthology) | |
| Disease | Febrile Convulsions | 8.88e-05 | 9 | 47 | 2 | C0009952 | |
| Disease | encephalitis (biomarker_via_orthology) | 8.88e-05 | 9 | 47 | 2 | DOID:9588 (biomarker_via_orthology) | |
| Disease | cystic fibrosis (implicated_via_orthology) | 8.88e-05 | 9 | 47 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 8.88e-05 | 9 | 47 | 2 | C3502809 | |
| Disease | early infantile epileptic encephalopathy (implicated_via_orthology) | 1.35e-04 | 11 | 47 | 2 | DOID:0050709 (implicated_via_orthology) | |
| Disease | Ulcerative Colitis | 1.41e-04 | 63 | 47 | 3 | C0009324 | |
| Disease | Asthma, Aspirin-Induced | 1.92e-04 | 13 | 47 | 2 | C1319853 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 1.92e-04 | 13 | 47 | 2 | C0751122 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.99e-04 | 181 | 47 | 4 | DOID:684 (is_implicated_in) | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 2.23e-04 | 14 | 47 | 2 | C1834558 | |
| Disease | MMR-related febrile seizures | 2.57e-04 | 15 | 47 | 2 | EFO_0006519 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 2.94e-04 | 16 | 47 | 2 | C0393706 | |
| Disease | Febrile seizure (within the age range of 3 months to 6 years) | 3.74e-04 | 18 | 47 | 2 | HP_0002373 | |
| Disease | Neurodevelopmental Disorders | 4.44e-04 | 93 | 47 | 3 | C1535926 | |
| Disease | end stage renal disease (implicated_via_orthology) | 4.63e-04 | 20 | 47 | 2 | DOID:783 (implicated_via_orthology) | |
| Disease | epilepsy (biomarker_via_orthology) | 5.12e-04 | 21 | 47 | 2 | DOID:1826 (biomarker_via_orthology) | |
| Disease | Neutropenia | 5.12e-04 | 21 | 47 | 2 | C0027947 | |
| Disease | status epilepticus (biomarker_via_orthology) | 5.50e-04 | 100 | 47 | 3 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Major Depressive Disorder | 6.06e-04 | 243 | 47 | 4 | C1269683 | |
| Disease | nephrotic syndrome (biomarker_via_orthology) | 6.70e-04 | 24 | 47 | 2 | DOID:1184 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | 7.09e-04 | 447 | 47 | 5 | C3714756 | |
| Disease | Unipolar Depression | 7.69e-04 | 259 | 47 | 4 | C0041696 | |
| Disease | obstructive sleep apnea (is_marker_for) | 9.81e-04 | 29 | 47 | 2 | DOID:0050848 (is_marker_for) | |
| Disease | rhinitis (is_implicated_in) | 1.05e-03 | 30 | 47 | 2 | DOID:4483 (is_implicated_in) | |
| Disease | Marijuana Abuse | 1.05e-03 | 30 | 47 | 2 | C0024809 | |
| Disease | asthma (is_marker_for) | 1.07e-03 | 126 | 47 | 3 | DOID:2841 (is_marker_for) | |
| Disease | arteriosclerosis (is_implicated_in) | 1.12e-03 | 31 | 47 | 2 | DOID:2349 (is_implicated_in) | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.27e-03 | 33 | 47 | 2 | DOID:9452 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FGRSFQYMQYGFLSM | 161 | Q8NAT2 | |
| QYMQYGFLSMFEVLN | 166 | Q8NAT2 | |
| NDFQRPAIYYMMSFS | 396 | O14977 | |
| MYLMNFFFLGAATAY | 1196 | Q99758 | |
| SAIMTGSYNNFFRMF | 361 | Q66LE6 | |
| FTGNFFYNYMMGIEF | 211 | Q9UBM7 | |
| TFSFTQAMMYFSYAG | 941 | P08183 | |
| QAMMYFSYAGCFRFG | 946 | P08183 | |
| TMKMFLFQFVNYYSS | 551 | Q4KMQ2 | |
| MMAYYSGNEDDLFFE | 11 | P01584 | |
| KTNYMEYFQEAMLFF | 411 | Q9NS87 | |
| MQFAFSYFYYLMSAV | 991 | Q3T906 | |
| SFGFYKYSNMEFVRM | 231 | Q6ICG6 | |
| MQMFFYVTLAGSEFF | 131 | Q8NH00 | |
| MMMDLFETGSYFFYL | 1 | P23409 | |
| YFAFAMTFFSLATML | 111 | P43116 | |
| FFLMEGGDTMYDFYT | 726 | Q96RT8 | |
| QLSMFASGLFYSMYI | 76 | O43934 | |
| GFCYLIYFNSMSQMN | 146 | Q86Y01 | |
| MDTTGYGNLRFYFVM | 466 | P78509 | |
| AYNMTFFPNLMGHYD | 36 | O60353 | |
| SSMEFKYDFNSSMLY | 3456 | P04114 | |
| YYLGMFMNSFAVFQE | 621 | Q6YHK3 | |
| FMVQMLTGIYFAFYN | 236 | Q9BYI3 | |
| MFAFAYTDLANMYAE | 336 | Q13325 | |
| MSSLYNFTGEQMAAY | 291 | P06756 | |
| EQHFMAGQSVMYYVF | 126 | U3KPV4 | |
| GMFVFGYDNYMAHAF | 136 | Q92611 | |
| ASQMAAFQDAYNFFY | 46 | Q8N7B9 | |
| YMVMSLLGHYNNFFF | 4796 | P21817 | |
| DSRMMYFSQYFNIVA | 326 | O43193 | |
| QMYFFMAFGNTDSYL | 101 | Q8NGR5 | |
| AQMYFFMAFGNTDSY | 136 | Q8NGR2 | |
| SYTGCLTQMYFFLMF | 91 | Q8NGS0 | |
| YFNMMYGDNSFSGLM | 721 | A2RUB1 | |
| PNYTNFQFDTSFMYM | 571 | Q8NBJ9 | |
| AFKYFLQGMGYMASS | 306 | Q9UN36 | |
| FYSFMIMKSNFDETY | 886 | Q8IVG5 | |
| FGCMTQMFFYAGFAT | 146 | Q8NGC0 | |
| LGYTSSLSFFFMMFF | 191 | Q8IZM9 | |
| MAFFNLYLLGYQNSF | 1 | A0A1B0GTD5 | |
| MFIYAIFGMSNFAYV | 1666 | Q9NY46 | |
| MFIYAIFGMSNFAYV | 1681 | P35498 | |
| NLYCSIFFMTAMSFF | 106 | Q9Y271 | |
| FYLGYNAMQDFFPTM | 281 | Q9GZZ9 | |
| PNYSNFQFDTSFMYM | 566 | Q9NXL6 | |
| FLDYEMGEISFYNMA | 416 | A6NK02 | |
| MFIYAIFGMSNFAYV | 1671 | Q99250 | |
| VMFIFSIFGMSNFAY | 1661 | Q9UQD0 | |
| AFLMYMNFYSSTAFL | 91 | Q8IYL9 | |
| SQFYMEDSFCHYNMF | 231 | Q9H5U6 | |
| NSETYWMTYTFSFFM | 61 | Q6PP77 | |
| FGQPLVFDMAYENYM | 201 | Q7L0Y3 | |
| SNISFFAMFVMYFLT | 311 | Q9H2H9 | |
| FAMFVMYFLTAIFGY | 316 | Q9H2H9 |